Modelli farmacodinamici: modello a effetto diretto e modello a risposta indiretta

Direct effect models link drug concentration directly to response for drugs rapidly reaching their site of action, with response proportional to concentration or following an Emax model. Indirect response models describe how drugs influence production or elimination of endogenous compounds, often displaying delayed peak responses and prolonged time to maximum effect at higher doses.

Models I and II describe inhibitory effects on response production and degradation, with Imax capped between 0 and 1. Models III and IV describe stimulatory effects, with maximum stimulation values always greater than 0, allowing drugs to enhance endogenous compound production or elimination.

Indirect response models show delayed peak responses because drugs influence production or degradation of endogenous substances rather than acting directly at the site of action. This mechanism results in gradual response changes, dose-independent initial rates, and prolonged time to maximum effect, particularly at higher doses.

Argatroban, an anticoagulant, demonstrates a direct effect model where its plasma concentrations directly relate to anticoagulant response following an Emax model. This rapid relationship between drug concentration and pharmacological effect exemplifies drugs that quickly reach their site of action and produce immediate responses.

Mizolastine's antihistaminic activity is modeled using indirect response methods to capture its impact on reducing flare area over time across varying doses. This approach reflects the delayed yet sustained effects characteristic of drugs that influence endogenous substance production or degradation rather than acting directly.

Pharmacodynamic models support dose selection and help assess early drug candidates during development by characterizing the dynamics of drug action. These models guide optimal dosing strategies and inform regulatory decisions by linking drug concentration to biological response, ensuring safer and more effective therapeutic interventions.

Indirect response models display gradual response changes, initial rates independent of dose, and prolonged time to maximum effect at higher doses, creating a delayed peak response. Direct effect models show immediate concentration-response relationships without these temporal delays or dose-independent initial rate characteristics.